轻度认知障碍的数字工具:对诊断准确度和方法挑战的系统审查和元分析
Aurora Bonvino1, Ester Cornacchia1, Giorgia Francesca Scaramuzzi2
1Dipartimento di Biomedicina Traslazionale e Neuroscienze - DiBraiN, Università Degli Studi Di Bari, Bari, Italy.
Neuropsychology review
|October 22, 2025
概括
数字工具在检测轻度认知障碍 (MCI) 中显示出有希望的准确性,这是痴呆症之前的关键中间阶段. 然而,研究质量和用户人口统计学,如年龄较大,可能会影响其有效性,需要标准化协议以获得更好的结果.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 数字健康数字健康
背景情况:
- 轻度认知障碍 (MCI) 表示正常衰老和明显痴呆之间的过渡阶段.
- 早期和精确的MCI诊断对于及时的治疗干预至关重要.
- 数字技术为多维数据采集和MCI的创新选提供了新的方法.
研究的目的:
- 进行元分析,评估MCI检测数字工具的诊断准确性.
- 评估研究质量,人口因素和技术熟悉度对诊断绩效的影响.
- 确定影响数字工具在识别MCI中的有效性的关键因素.
主要方法:
- 对32项研究进行了元分析,以评估MCI检测的数字工具准确性.
- 计算了聚合灵敏度和特异性,以及异质性评估 (I2).
- 使用分层汇总接收器操作特征 (HSROC) 分析和元回归来探索变化和影响因素.
主要成果:
- 对于MCI检测中的数字工具,元分析报告了0.808的聚合灵敏度和0.795的特异性.
- 在诊断性能中观察到显著的异质性 (I2 = 71.5%的灵敏度,84.0%的特异性).
- 超回归表明,适用性问题和年龄较大与特异性降低有关.
结论:
- 数字工具显示出MCI查的巨大潜力,总体而言,诊断准确性是有前途的.
- 研究质量的异质性和人口因素,特别是年龄较大,影响了工具的性能.
- 标准化的协议,严格的验证和量身定制的调整对于优化MCI检测数字工具有效性至关重要.
更多相关视频
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552
Dementia
515
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
515
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
